These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17278300)

  • 21. [Bronchodilator effects of terbutaline in injection].
    Gayrard P; Orehek J; Charpin J
    Poumon Coeur; 1972; 28(2):91-6. PubMed ID: 4146732
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of the effects of salbutamol, fenoterol, and placebo aerosols on airway resistance in asthmatics.
    Siddorn JA
    Med J Zambia; 1976 Dec-1977 Jan; 10(6):153-6. PubMed ID: 14454
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on new sympathomimetic beta-receptor stimulating drugs in asthmatic patients. I. The bronchodilator and circulatory effects of subcutaneous terbutaline.
    Da Costa JL; Goh BK
    Singapore Med J; 1973 Jun; 14(2):120-3. PubMed ID: 4147473
    [No Abstract]   [Full Text] [Related]  

  • 24. Formoterol dry powder in asthma.
    Bright P
    Thorax; 1994 Jan; 49(1):95. PubMed ID: 7908764
    [No Abstract]   [Full Text] [Related]  

  • 25. [The inhibitory effect of long-acting beta-adrenergic agonists, mabuterol, clenbuterol and fenoterol on "morning dipping" in patients with asthma].
    Yamamoto H; Nagata M; Tabe K; Suzuki S; Maruo H; Sakamoto Y; Yamamoto K; Dohi Y
    Arerugi; 1990 Jan; 39(1):21-7. PubMed ID: 1972011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Duration of the therapeutic effect of a beta 2 stimulant (procaterol hydrochloride) in patients with asthmatiform bronchopathies].
    Cammarata A; Mazzarella G; Grella E; Liccardo G
    Arch Monaldi Mal Torace; 1988; 43(2):131-40. PubMed ID: 2908377
    [No Abstract]   [Full Text] [Related]  

  • 27. Formoterol as relief medication in asthma: the jury is still out.
    Jenkins C
    Eur Respir J; 2003 Nov; 22(5):723-4. PubMed ID: 14621074
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of a new B 2 adrenergic receptor stimulant, terbutaline, in bronchial asthma. I. Subcutaneous comparison with epinephrine.
    Glass P; Dulfano MJ
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):141-9. PubMed ID: 4144566
    [No Abstract]   [Full Text] [Related]  

  • 29. Life-threatening asthma during treatment with salmeterol.
    Weinberger M; Abu-Hasan M
    N Engl J Med; 2006 Aug; 355(8):852-3. PubMed ID: 16929006
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical testing of bronchospasmolytics in combined alternating test schedules].
    Kaik G
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):97-106. PubMed ID: 3472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a new B 2 adrenergic receptor stimulant, terbutaline, in bronchial asthma. II. Oral comparison with ephedrine.
    Dulfano MJ; Glass P
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):150-7. PubMed ID: 4144567
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-acting inhaled beta 2-agonists and the loss of "bronchoprotective" efficacy.
    Abisheganaden J; Boushey HA
    Am J Med; 1998 May; 104(5):494-7. PubMed ID: 9626035
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of formoterol on light or moderate bronchial asthma due to allergy to Parietaria officinalis].
    Pacor ML; Biasi D; Carletto A; Maleknia T; Lunardi C
    Clin Ter; 1996 Nov; 147(11):567-70. PubMed ID: 9264910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salmeterol and formoterol: asthma aggravation. Use should be restricted.
    Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19743580
    [No Abstract]   [Full Text] [Related]  

  • 35. Asthma. Bronchodilators: new developments.
    Tattersfield AE
    Br Med Bull; 1992 Jan; 48(1):190-204. PubMed ID: 1352168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-adrenergic bronchodilators.
    Nelson HS
    N Engl J Med; 1995 Aug; 333(8):499-506. PubMed ID: 7623883
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-acting inhaled beta 2-agonists in the management of asthma: recent advances and current recommendations.
    Redington AE; Rees PJ
    Int J Clin Pract; 1998 Oct; 52(7):482-6. PubMed ID: 10622090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An analysis of the utilisation and expenditure of medicines dispensed for the management of severe asthma.
    McGowan B; Bennett K; Barry M; Owens M; O'Connor M
    Ir Med J; 2009 Mar; 102(3):73-6. PubMed ID: 19489193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Budesonide + formoterol: new dose regimen. Asthma attacks: a step backwards.
    Prescrire Int; 2008 Apr; 17(94):57. PubMed ID: 18516807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study of a vagolytic and a beta 2 sympathomimetic drug on the respiratory function of the asthmatic patient].
    Ramonatxo M; Prefaut C; Tronc JF; Michel FB; Chardon G
    Poumon Coeur; 1978; 34(2):95-9. PubMed ID: 149968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.